Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Sanofi (SNY) Leases (2018 - 2026)

Sanofi's Leases history spans 9 years, with the latest figure at $1.8 billion for Q1 2026.

  • On a quarterly basis, Leases rose 10.14% to $1.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.8 billion, a 10.14% increase, with the full-year FY2025 number at $1.7 billion, up 5.25% from a year prior.
  • Leases hit $1.8 billion in Q1 2026 for Sanofi, up from $1.7 billion in the prior quarter.
  • Over the last five years, Leases for SNY hit a ceiling of $2.0 billion in Q2 2022 and a floor of $94.9 million in Q4 2022.
  • Historically, Leases has averaged $1.6 billion across 5 years, with a median of $1.7 billion in 2025.
  • Biggest five-year swings in Leases: soared 1775.58% in 2023 and later decreased 9.33% in 2024.
  • Tracing SNY's Leases over 5 years: stood at $94.9 million in 2022, then soared by 1775.58% to $1.8 billion in 2023, then decreased by 9.33% to $1.6 billion in 2024, then rose by 5.25% to $1.7 billion in 2025, then increased by 4.57% to $1.8 billion in 2026.
  • Business Quant data shows Leases for SNY at $1.8 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.7 billion in Q3 2025.